1 Department of Technology and Social Sciences, Technical University of Denmark2 National Institute for Agronomic Research3 Department of Management Engineering, Technical University of Denmark
Implications for European Competitiveness in Biotechnology
The point of departure of our analysis was the relative weakness of European SME's vis-a-vis American and Japanese companies. With a growth in the figures for numbers of SME's in European biotechnology and stagnation in the figures of U.S.A. it seems that a bridging numerically between Europe and U.S.A. can be observed. However this by no means implies that the technological capability gap is disappering. A first cause for the American strength can be found in the availability of venture capital in U.S.A..